← Back to Search

Other

Topical Bacteria + Cardamom for Eczema

Phase 3
Waitlist Available
Led By Ian A Myles, M.D.
Research Sponsored by National Institute of Allergy and Infectious Diseases (NIAID)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Major Criteria: Must have >=3 basic features: Pruritus, Typical morphology and distribution (flexural lichenification in adults, facial and extensor eruptions in infants and children), Chronic or chronically relapsing dermatitis, Personal or family history of atopy (asthma, allergic rhinitis, AD)
Sexually active participants of childbearing potential must agree to use adequate methods of contraception from the screening visit continuously until 30 days after stopping treatment with the investigational product. Childbearing potential is defined for children as participants who have begun menstruating and for adults as participants who are not surgically sterile (hysterectomy and/or tubal ligation) or menopausal (age >=45 years plus no menses for 12 consecutive months without an alternative medical cause). Adequate contraception methods include: a barrier method (eg, condom use), oral contraceptive pill, hormonal patch or ring, hormonal injection, parenteral hormonal implant, or an intrauterine device.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 7 to week 28
Awards & highlights

Study Summary

This trial tests whether a topical formulation of live bacteria and cardamom seeds can improve symptoms of atopic dermatitis and last beyond active treatment.

Who is the study for?
This trial is for people aged 2 years and older with atopic dermatitis (AD), also known as eczema. Participants must be willing to do virtual visits, speak English, have a primary care provider nearby, and use contraception if of childbearing potential. They should not have used certain AD treatments recently or have infections needing systemic treatment.Check my eligibility
What is being tested?
The study tests a skin treatment combining Roseomonas mucosa bacteria and ground cardamom seeds against a placebo. Over about 7 months, participants will apply the mixture or placebo to their skin several times per week and complete online questionnaires.See study design
What are the potential side effects?
Potential side effects are not detailed in the provided information but could include typical reactions to topical treatments such as skin irritation, redness, or itching. Since this is an investigational product, unexpected side effects may occur.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have at least 3 symptoms of eczema, including itching, skin rash, and a history of allergies.
Select...
I agree to use birth control during and 30 days after treatment if I can have children.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 7 to week 28
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 7 to week 28 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
To determine if R mucosa combined with ground cardamom seeds can improve symptoms of AD in patients aged 2 and older, 14 weeks after treatment discontinuation.
Secondary outcome measures
To determine if R mucosa combined with ground cardamom seeds can improve symptoms of AD in patients aged 2 and older, during active treatment as well as 7 weeks after treatment discontinuation.

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: ActiveActive Control1 Intervention
Roseomonas and Cardamom seeds
Group II: PlaceboPlacebo Group1 Intervention
Sucrose

Find a Location

Who is running the clinical trial?

National Institute of Allergy and Infectious Diseases (NIAID)Lead Sponsor
3,277 Previous Clinical Trials
5,487,213 Total Patients Enrolled
Ian A Myles, M.D.Principal InvestigatorNational Institute of Allergy and Infectious Diseases (NIAID)
5 Previous Clinical Trials
360 Total Patients Enrolled
~160 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top